254 filings
Page 2 of 13
8-K
2newek
1 Jun 23
Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
7:29am
8-K
6vxostg 05ojb15
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
b5bpkegu
2 May 23
Departure of Directors or Certain Officers
4:05pm
8-K
dg5i11lrr5sg9q9ks
14 Apr 23
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
4:39pm
8-K
b43008s7
6 Apr 23
Regulation FD Disclosure
4:10pm
8-K/A
01sii522st
27 Mar 23
Financial Statements and Exhibits
4:32pm
8-K
0kbdnrlcvf s2m5euur
16 Mar 23
Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results
4:31pm
8-K
f15o lzm1f345tw6
3 Mar 23
Departure of Directors or Certain Officers
4:20pm
8-K
4f2su7h59
7 Feb 23
Entry into a Material Definitive Agreement
4:48pm
8-K
cyq7yty380pkg z4z
31 Jan 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:47pm
8-K
jo7aj6tw7r dbnirj
11 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:58pm
8-K
spmag1kvx bstv
9 Jan 23
Entry into a Material Definitive Agreement
9:32pm
8-K
ngpw touzbm5rgn
25 Nov 22
Entry into a Material Definitive Agreement
4:51pm
8-K
2drsmo mb
16 Nov 22
Lifecore Biomedical Announces Completion of Corporate Name Change
4:47pm
8-K
yr3irdqwue1 2w231u
7 Nov 22
Departure of Directors or Certain Officers
4:05pm
8-K
sk88v
6 Oct 22
Landec Corporation Reports First Quarter Fiscal Year 2023 Results
7:17am
8-K
vigz 25hnv8b
13 Sep 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
9:45pm
8-K
xmh6t 8l9
9 Sep 22
Landec Corp. Receives Notice from Nasdaq Regarding Delayed Annual Report
4:34pm
8-K
x6k0 hxtm
10 Aug 22
Landec Corporation Reports Fourth Quarter and Full Fiscal Year 2022 Results
4:20pm
8-K
3l09d5
2 Jun 22
Regulation FD Disclosure
4:10pm